News
Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.
6d
Investing News Network on MSNBiotech and Pharma Market Update: Q2 2025 in ReviewThe second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...
France's Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by strong ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
14h
New Scientist on MSNHuman trials point the way towards an mRNA vaccine against HIVWe may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
5d
News-Medical.Net on MSNNew model predicts mRNA protein production, accelerating drug and vaccine discoveryA new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...
Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...
2d
Pharmaceutical Technology on MSNSanofi’s Sarclisa gains EC approval for multiple myeloma treatmentThe European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, ...
Another FTSE 100-listed ( ^FTSE) giant reporting in the week ahead is pharmaceuticals company AstraZeneca ( AZN.L ), which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results